Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CELESTICA INCCLS · Entity 3096 | Director | September 30, 2026 | October 02, 2026 |
| KORU Medical Systems, Inc.KRMD · Entity 6517 | Director | October 01, 2026 | October 01, 2026 |
| Mirion Technologies, Inc.MIR · Entity 394 | Director | May 13, 2026 | May 14, 2026 |
| Neuronetics, Inc.STIM · Entity 6248 | Director | May 28, 2026 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CELESTICA INC
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 272 |
Ending reported balance
After 2026-09-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-30 · Exercise / conversion · Acquired 52 · Balance 278 Row 2 · 2026-09-30 · Tax withholding · Disposed 6 · Balance 272 F1: Shares withheld to satisfy tax withholding obligations arising out of the vesting of restricted share units ("RSUs"). |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 105 |
Reported balance
After 2026-09-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-30 · Exercise / conversion · Disposed 52 · Balance 105 F2: Each RSU represents a contingent right to receive one common share or an equivalent value in cash at the holder's election. F3: On September 30, 2025, the reporting person was granted 157 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld to satisfy tax withholding obligations arising out of the vesting of restricted share units ("RSUs").
F2: Each RSU represents a contingent right to receive one common share or an equivalent value in cash at the holder's election.
F3: On September 30, 2025, the reporting person was granted 157 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.
KORU Medical Systems, Inc.
Report date October 01, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 103,274 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 5,119 · Balance 103,274 |
Mirion Technologies, Inc.
Report date May 13, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 60,801 |
Reported balance
After 2026-05-13 transaction · row 1
1 source rowRow 1 · 2026-05-13 · Grant · Acquired 7,383 · Balance 60,801 F1: Represents restricted stock units that will vest on the earlier to occur of (i) first anniversary of the grant date or (ii) date of the annual stockholder meeting following the grant date, subject to the non-employee director's continued service on the Board through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that will vest on the earlier to occur of (i) first anniversary of the grant date or (ii) date of the annual stockholder meeting following the grant date, subject to the non-employee director's continued service on the Board through such vesting date.
Neuronetics, Inc.
Report date May 28, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 625,017 |
Reported balance
After 2026-05-28 transaction · row 1
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 36,250 · Balance 625,017 F1: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date.
F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 1, 2026 21:23 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,119 | $2.93 | $14,998.67 |
DisclosureSEC source: 0001161697-26-000221 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,274 Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 00:26 UTC | CELESTICA INC CLS · Entity 3096 | Exercise / conversionRestricted Share Units · Derivative | 52 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-410716 · ownership.xml · derivative · entry 3 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105 Underlying: Common Shares · 52 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one common share or an equivalent value in cash at the holder's election. F3 · derivative.exercise_date: On September 30, 2025, the reporting person was granted 157 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. F3 · derivative.expiration_date: On September 30, 2025, the reporting person was granted 157 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 00:26 UTC | CELESTICA INC CLS · Entity 3096 | Tax withholdingCommon Shares | 6 | $366.47 | $2,198.82 |
DisclosureSEC source: 0001193125-26-410716 · ownership.xml · nonDerivative · entry 2 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272 F1 · shares: Shares withheld to satisfy tax withholding obligations arising out of the vesting of restricted share units ("RSUs"). Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 00:26 UTC | CELESTICA INC CLS · Entity 3096 | Exercise / conversionCommon Shares | 52 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-410716 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:44 UTC | CELESTICA INC CLS · Entity 3096 | GrantDirector Restricted Share Units · Derivative | 142 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-347020 · ownership.xml · derivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 761 Underlying: Common Shares · 142 shares Expires not disclosed F1 · derivative.exercise_price: Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash. F2 · derivative.exercise_date: On August 11, 2026, the reporting person was granted 142 D-RSUs, which vest on May 20, 2027. F2 · derivative.expiration_date: On August 11, 2026, the reporting person was granted 142 D-RSUs, which vest on May 20, 2027. Read SEC document |
| July 01, 2026 Filed Jul 1, 2026 21:17 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,571 | $4.20 | $14,998.20 |
DisclosureSEC source: 0001161697-26-000143 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,155 Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:17 UTC | CELESTICA INC CLS · Entity 3096 | Exercise / conversionRestricted Share Units · Derivative | 84 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-294580 · ownership.xml · derivative · entry 3 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169 Underlying: Common Shares · 84 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one common share or an equivalent value in cash at the holder's election. F3 · derivative.exercise_date: On June 30, 2025, the reporting person was granted 253 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. F3 · derivative.expiration_date: On June 30, 2025, the reporting person was granted 253 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:17 UTC | CELESTICA INC CLS · Entity 3096 | Tax withholdingCommon Shares | 5 | $343.25 | $1,716.25 |
DisclosureSEC source: 0001193125-26-294580 · ownership.xml · nonDerivative · entry 2 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226 F1 · shares: Shares withheld to satisfy tax withholding obligations arising out of the vesting of restricted share units ("RSUs"). Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:17 UTC | CELESTICA INC CLS · Entity 3096 | Exercise / conversionCommon Shares | 84 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-294580 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:01 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 36,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001218713-26-000002 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,017 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 20, 2026 Filed May 20, 2026 23:36 UTC | CELESTICA INC CLS · Entity 3096 | GrantDirector Restricted Share Units · Derivative | 619 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-233047 · ownership.xml · derivative · entry 2 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 619 Underlying: Common Shares · 619 shares Expires not disclosed F3 · derivative.exercise_price: Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash. F4 · derivative.exercise_date: On May 20, 2026, the reporting person was granted 619 D-RSUs, which vest on the first anniversary of the grant date. F4 · derivative.expiration_date: On May 20, 2026, the reporting person was granted 619 D-RSUs, which vest on the first anniversary of the grant date. Read SEC document |
| May 19, 2026 Filed May 20, 2026 23:36 UTC | CELESTICA INC CLS · Entity 3096 | GrantRestricted Share Units · Derivative | 58 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-233047 · ownership.xml · derivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58 Underlying: Common Shares · 58 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election. F2 · derivative.exercise_date: On May 19, 2026, the reporting person was granted 58 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. F2 · derivative.expiration_date: On May 19, 2026, the reporting person was granted 58 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Read SEC document |
| May 13, 2026 Filed May 14, 2026 20:07 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 7,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035094 · wk-form4_1778789273.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,801 F1 · shares: Represents restricted stock units that will vest on the earlier to occur of (i) first anniversary of the grant date or (ii) date of the annual stockholder meeting following the grant date, subject to the non-employee director's continued service on the Board through such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 1, 2026 20:48 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,472 | $4.32 | $14,999.04 |
DisclosureSEC source: 0001161697-26-000080 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,584 Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:20 UTC | CELESTICA INC CLS · Entity 3096 | GrantRestricted Share Units · Derivative | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-140198 · ownership.xml · derivative · entry 4 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150 Underlying: Common Shares · 150 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one common share or an equivalent value in cash at the holder's election. F4 · derivative.exercise_date: On March 31, 2026, the reporting person was granted 150 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. F4 · derivative.expiration_date: On March 31, 2026, the reporting person was granted 150 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:20 UTC | CELESTICA INC CLS · Entity 3096 | Exercise / conversionRestricted Share Units · Derivative | 156 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-140198 · ownership.xml · derivative · entry 3 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312 Underlying: Common Shares · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one common share or an equivalent value in cash at the holder's election. F3 · derivative.exercise_date: On March 31, 2025, the reporting person was granted 468 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. F3 · derivative.expiration_date: On March 31, 2025, the reporting person was granted 468 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:20 UTC | CELESTICA INC CLS · Entity 3096 | Tax withholdingCommon Shares | 9 | $257.27 | $2,315.43 |
DisclosureSEC source: 0001193125-26-140198 · ownership.xml · nonDerivative · entry 2 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147 F1 · shares: Shares withheld to satisfy tax withholding obligations arising out of the vesting of restricted share units ("RSUs"). Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:20 UTC | CELESTICA INC CLS · Entity 3096 | Exercise / conversionCommon Shares | 156 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-140198 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:51 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 2,581 | $5.81 | $14,995.61 |
DisclosureSEC source: 0001161697-26-000009 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,112 Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:17 UTC | CELESTICA INC CLS · Entity 3096 | GrantRestricted Share Units · Derivative | 129 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-002452 · ownership.xml · derivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129 Underlying: Common Shares · 129 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election. F2 · derivative.exercise_date: On December 31, 2025, the reporting person was granted 129 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. F2 · derivative.expiration_date: On December 31, 2025, the reporting person was granted 129 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Read SEC document |
| October 20, 2025 Filed Oct 22, 2025 20:45 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 10,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-246923 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 588,767 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · shares: Represents a restricted stock unit ("RSU") award that vested immediately upon the grant. F3 · price: Each RSU represents a right to receive one share of the Issuer's common stock. Read SEC document |
| October 02, 2025 Filed Oct 2, 2025 20:35 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,916 | $3.83 | $14,998.28 |
DisclosureSEC source: 0001161697-25-000332 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,531 Read SEC document |
| September 30, 2025 Filed Oct 1, 2025 22:29 UTC | CELESTICA INC CLS · Entity 3096 | GrantRestricted Share Units · Derivative | 157 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-227150 · ownership.xml · derivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157 Underlying: Common Shares · 157 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election. F2 · derivative.exercise_date: On September 30, 2025, the reporting person was granted 157 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. F2 · derivative.expiration_date: On September 30, 2025, the reporting person was granted 157 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Read SEC document |
| July 02, 2025 Filed Jul 2, 2025 21:17 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 4,189 | $3.58 | $14,996.62 |
DisclosureSEC source: 0001161697-25-000207 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,615 Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 20:19 UTC | CELESTICA INC CLS · Entity 3096 | GrantRestricted Share Units · Derivative | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-092222 · ownership.xml · derivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253 Underlying: Common Shares · 253 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election. F2 · derivative.exercise_date: On June 30, 2025, the reporting person was granted 253 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. F2 · derivative.expiration_date: On June 30, 2025, the reporting person was granted 253 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 36,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077828 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 578,236 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 22, 2026 or (b) the Reporting Person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 15, 2025 Filed May 16, 2025 20:15 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 7,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026275 · wk-form4_1747426506.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,418 F1 · shares: Represents restricted stock units that will vest in four equal quarterly installments on September 15, 2025, December 15, 2025, March 15, 2026, and the earlier to occur of (i) first anniversary of the grant date or (ii) date of the annual stockholder meeting following the grant date, subject to the non-employee director's continued service on the Board through each such vesting date. Read SEC document |
| April 02, 2025 Filed Apr 2, 2025 20:29 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,870 | $2.56 | $15,027.20 |
DisclosureSEC source: 0001161697-25-000131 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,426 Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:18 UTC | CELESTICA INC CLS · Entity 3096 | GrantRestricted Share Units · Derivative | 468 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-049356 · ownership.xml · derivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 468 Underlying: Common Shares · 468 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election. F2 · derivative.exercise_date: On March 31, 2025, the reporting person was granted 468 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. F2 · derivative.expiration_date: On March 31, 2025, the reporting person was granted 468 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 22:13 UTC | Neuronetics, Inc. STIM · Entity 6248 | OtherCommon Stock | 88,888 | $2.25 | $199,998.00 |
DisclosureSEC source: 0000950170-25-017184 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 541,986 F1 · kind: On February 7, 2025, the Reporting Person purchased 88,888 shares of the Issuer's Common Stock in connection with a firm commitment underwritten offering. Read SEC document |
| January 03, 2025 Filed Jan 3, 2025 21:29 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,937 | $3.81 | $14,999.97 |
DisclosureSEC source: 0001161697-25-000018 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,556 Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 21:10 UTC | CELESTICA INC CLS · Entity 3096 | GrantDeferred Share Units · Derivative | 419 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-000430 · ownership.xml · derivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,793 Underlying: Common Shares · 419 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share unit represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to be (a) a director of the Issuer or (b) an employee of the Issuer. F1 · derivative.exercise_date: Each deferred share unit represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to be (a) a director of the Issuer or (b) an employee of the Issuer. F1 · derivative.expiration_date: Each deferred share unit represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to be (a) a director of the Issuer or (b) an employee of the Issuer. Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:03 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,454 | $2.75 | $14,998.50 |
DisclosureSEC source: 0001161697-24-000403 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,978 Read SEC document |
| October 01, 2024 Filed Jan 3, 2025 15:08 UTC Amendment | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,454 | $2.75 | $14,998.50 |
DisclosureSEC source: 0001161697-25-000008 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,619 Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 21:02 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 100,000 | $0.75 | $75,000.00 |
DisclosureSEC source: 0000950170-24-106434 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,098 Read SEC document |
| August 19, 2024 Filed Aug 19, 2024 21:13 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 4,000 | $1.14 | $4,560.00 |
DisclosureSEC source: 0000950170-24-098675 · ownership.xml · nonDerivative · entry 2 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 353,098 Read SEC document |
| August 16, 2024 Filed Aug 19, 2024 21:13 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 35,000 | $1.06 | $37,100.00 |
DisclosureSEC source: 0000950170-24-098675 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,098 Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 35,000 | $0.88 | $30,800.00 |
DisclosureSEC source: 0000950170-24-098143 · ownership.xml · nonDerivative · entry 2 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,098 Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 21:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 35,000 | $0.79 | $27,650.00 |
DisclosureSEC source: 0000950170-24-098143 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,098 Read SEC document |
| July 11, 2024 Filed Jul 12, 2024 14:41 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,545 | $2.71 | $15,026.95 |
DisclosureSEC source: 0001161697-24-000306 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,524 Read SEC document |
| July 11, 2024 Filed Jan 3, 2025 15:07 UTC Amendment | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,545 | $2.71 | $15,026.95 |
DisclosureSEC source: 0001161697-25-000006 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,165 Read SEC document |
| June 06, 2024 Filed Jun 6, 2024 21:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 50,000 | $2.05 | $102,550.00 |
DisclosureSEC source: 0000950170-24-069983 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,098 Read SEC document |
| June 04, 2024 Filed Jun 4, 2024 20:47 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 13,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026617 · wk-form4_1717534063.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,441 F1 · shares: Represents restricted stock units that will vest in four equal quarterly installments on September 15, 2024, December 15, 2024, March 15, 2025, and the earlier to occur of (i) first anniversary of the grant date or (ii) date of the annual stockholder meeting following the grant date, subject to the non-employee director's continued service on the Board through each such vesting date. Read SEC document |
| May 30, 2024 Filed Jun 6, 2024 00:22 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 31,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-069576 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,098 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 30, 2025, or (b) the reporting person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the reporting person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 31, 2024 Filed Apr 1, 2024 20:08 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 6,329 | $2.37 | $14,999.73 |
DisclosureSEC source: 0001161697-24-000166 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,620 Read SEC document |
| December 31, 2023 Filed Jan 2, 2024 21:47 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 6,329 | $2.37 | $14,999.73 |
DisclosureSEC source: 0001161697-24-000005 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,291 Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 20:14 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,484 | $2.74 | $15,026.16 |
DisclosureSEC source: 0001161697-23-000514 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,962 Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 20:13 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | PurchaseCommon Stock | 19,000 | $2.61 | $49,533.00 |
DisclosureSEC source: 0001161697-23-000458 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,478 Read SEC document |
| August 10, 2023 Filed Aug 11, 2023 21:56 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 28,500 | $1.81 | $51,670.50 |
DisclosureSEC source: 0001062993-23-016291 · form4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,848 Read SEC document |
| August 10, 2023 Filed Sep 20, 2023 22:15 UTC Amendment | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 28,500 | $1.81 | $51,670.50 |
DisclosureSEC source: 0001062993-23-018358 · form4a.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,848 F1 · kind: This amendment is being filed to correct the Transaction Code (as set forth in Box 3). The Form 4, as originally filed, inadvertently reported the Transaction Code as "A." Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.